Research Project Title |
Acronym |
Data controler |
Lawfulness of processing |
Recipients of the data |
Data retention period |
Category of data |
Transfer outside the EU |
Association between depressive and anxious symptoms and morbidity after surgery in esogastric cancer patients |
DAMCHIR / ANDEMOCHIR |
Lille university, CNRS UMR 9193 |
Public interest |
Academic |
Completion of research |
Clinical data - Questionnaires |
No |
Effect of patients' perceived medical empathy and emotional competence on their adjustment to cancer |
CEMA |
Lille university, CNRS UMR 9193 |
Public interest |
Academic |
Completion of research |
Clinical data - Questionnaires |
No |
Establishment of functional molecular signatures of gastroesophageal junction (GEJ) adenocarcinomas and role in treatment response |
EASTMAN |
Lille university, CNRS UMR 8161 |
Public interest |
Academic |
Completion of research |
Clinical data –Tumours samples |
No |
Impact of patient-physician emotional regulation on the patient's medical outcome |
EMOVOL |
Lille university, CNRS UMR 9193 |
Public interest |
Academic |
Completion of research |
Clinical data - Questionnaires |
No |
Stomach Genome Wide Association Studies |
GWAS stomach |
CHU de Lille |
Public interest |
Academic |
Completion of research |
Clinical data –blood samples |
No |
Role of socioeconomic and environmental inequalities on esogastric cancers |
INEKOG |
Lille university, UMR CNRS 9221 |
Public interest |
Academic |
Completion of research |
Clinical data - Questionnaires |
No |
Post esophagectomy mortality root cause analysis |
PEMRCA |
AP-HP |
Public interest |
Academic |
Completion of research |
Clinical data |
No |
Molecular profiling of esogastric adenocarcinoma recurrences |
PROMOREC |
CHU de Lille |
Public interest |
Academic |
Completion of research |
Clinical data –Tumours samples |
No |
Identification of therapeutic targets of recurrent gastric cell carcinoma by very high-throughput sequencing |
REComics |
CHU de Lille |
Public interest |
Academic |
Completion of research |
Clinical data –Tumours samples |
No |
Impact of FDG PET after neoadjuvant radiochemotherapy in esophageal cancer patients: value of follow-up? |
TEP-oeso-RCT |
CHU de Lille |
Public interest |
Academic |
Completion of research |
Clinical data |
No |
Value of histologic response to preoperative chemotherapy in predicting the efficacy of postoperative chemotherapy in gastric adenocarcinoma |
TRG |
CHU de Lille |
Public interest |
Academic |
Completion of research |
Clinical data |
No |
Assessment and emotional determinants of health-related quality of life deterioration in patients with esogastric cancer |
DETAVIE |
CHU de Besançon |
Public interest |
Academic |
Completion of research |
Clinical data - Questionnaires |
No |
Understanding the molecular mechanisms associated with tumor resistance in gastric adenocarcinoma |
miniPRESTO |
Institut régional du cancer de Montpellier |
Public interest |
Academic |
Completion of research |
Clinical data –Tumours samples |
No |
Biological analyses and response to therapy of esogastric adenocarcinomas with microsatellite instability |
ARTEMSI |
CHU de Lille |
Public interest |
Academic |
Completion of research |
Clinical data –Tumours samples |
No |
MS Guide surgery for gastric cancer |
MS Guide |
Lille university, INSERM U1192 |
Public interest |
Academic |
Completion of research |
Clinical data –Tumours samples |
No |
Development of a statistical model for the prediction of MSI status from digitized H&E slides of tumor tissue |
MSI-IA |
CHU de Lille |
Public interest |
Academic |
Completion of research |
Clinical data –Tumours samples |
No |
Using artificial intelligence to predict the molecular subtype and oncologic outcome of patients with adenocarcinoma of the stomach |
FREGANET |
CHU de Lille |
Public interest |
Academic |
Completion of research |
Clinical data –Tumours samples |
No |
Using artificial intelligence to predict the molecular subtype and oncologic outcome of patients with esophageal adenocarcinoma |
FREGATIA |
CHU de Lille |
Public interest |
Academic |
Completion of research |
Clinical data –Tumours samples |
No |
Assessment of the predictive value of plasma proteins in oesophageal adenocarcinoma treatment |
ASPECT |
St Andrews University (Scotland) |
Public interest |
Academic |
Completion of research |
Clinical data –blood samples |
No |
Identification of rare and penetrating germline mutations and genes for gastric cancer, diagnosed before age 50 |
WES stomach |
University Hospital of Marburg, Center for Human genetics (Germany) |
Public interest |
Academic |
Completion of research |
Clinical data –blood samples |
No |
2019-01 |
2019-01 |
Industrial |
Public interest |
Industrial |
Completion of research |
Clinical data |
No |
2020-01 |
2020-01 |
Industrial |
Public interest |
Industrial |
Completion of research |
Clinical data |
No |
nOde Metastasis EsoGastric cAncer |
OMEGA | Association pour l’étude des maladies digestives | Public interest | Academic | Completion of research | Clinical data | No |
Effects of centralization of cancer care on patients' quality of life. Analysis and perspectives from the FREGAT cohort (oesogastric cancers). | CENTRAVIE | Centre Léon Bérard | Public interest | Academic | Completion of research | Clinical data - Questionnaires | No |
Disease burden, epidemiology, treatment patterns and healthcare resource utilization in France for locally advanced unresectable or metastatic adenocarcinoma of gastric and gastroesophageal Junction (G/GEJ): an analysis using the FREnch EsoGAstric Tumours (FREGAT) Database | BECOME | Astellas | Public interest | Industrial | Completion of research | Clinical data | No |
Feasibility and efficacy of perioperative treatment in patients over 75 years managed for localized adenocarcinoma of the stomach or GEJ. | STOMAGE | CHU de Lille | Public interest | Academic | Completion of research | Clinical data | No |
Defining Predictive Immunedeterminants of response to neoadjuvant Chemoradiation in Oesophageal adenocarcinoma. |
PREDICO |
San Raffaele Scientific Institute (Italy) |
Public interest |
Academic |
Completion of research |
Clinical data –Tumours and blood samples |
No |
Dissecting metabolic hetergoneity in oesophageal cancer to increase immunotherapy afficacy and overcome resistance |
IMPROVE |
Institut Pasteur Lille |
Public interest |
Academic |
Completion of research |
Clinical data –Tumours |
No |
Real world management and outcomes of patients with non-metastatic esophageal squamous cell carcinoma in the FREGAT database |
2024-01 |
CHU de Lille |
Public interest |
Academic |
Completion of research |
Clinical data |
No |
Determination of microbiological factors predictive of response to neoadjuvant therapy in non-metastatic esophageal adenocarcinoma nd esogastric junction |
MICADOE |
CHU de Lille |
Public interest |
Academic |
Completion of research |
Clinical data |
No |
Impact of the COVID-19 pandemic on the stage at diagnosis, treatment and prognosis of patients with esogastric cancer in the FREGAT ohort |
CAGOCOVID |
CHU de Reims |
Public interest |
Academic |
Completion of research |
Clinical data |
No |